Effects of nutraceuticals on sexual satisfaction and lower urinary tract symptoms in a cohort of young–old men. (23rd November 2017)

• Record Type: Journal Article
• Authors: Perri, Anna; Ilacqua, Alessandro; Valenti, Marina; Aversa, Antonio
• Is Part Of: Phytotherapy research. Volume 32:Number 2(2018)
• Page Start: 284
• Page End: 289
• Publication Date: 2017-11-23
• Subjects: aging -- antioxidants -- distress -- erection -- sexual desire -- supplements; Materia medica, Vegetable -- Periodicals; Botany, Medical -- Periodicals; Medicinal plants -- Periodicals; Plant Extracts -- therapeutic use -- Periodicals; Plants, Medicinal -- Periodicals; 581.634
• DOI: 10.1002/ptr.5971
• Languages: English
• ISSNs: 0951-418X

Abstract

Abstract : The aim of this study was to evaluate the effects of nutraceuticals containing multiple supplemental facts (Virherbe®/Rekupros®) on sexual satisfaction and lower urinary tract symptoms (LUTS) in young–old men. In an open‐label trial, 40 males (mean age 66 ± 13) with sexual disturbances and mild LUTS but without cognitive/motor impairment and clinical hypogonadism were enrolled. Sexual desire (SD; IIEF‐SD domain) and satisfaction (Global Assessment Question; GAQ), the capacity to perform daily activities (evaluated by 6‐min walking test [6MWT]), and International Prostate Symptoms Scores (IPSS) were evaluated before and after oral administration of 2 capsules/day of each supplement for 8 weeks. The difference from baseline for SD was +2.6 ( p < .05) and −4.2 points for IPSS ( p < .05), with significance in subscales of urinary streaming/nocturia ( p < .01), respectively; 6MWT increased from 507 ± 44 versus 527 ± 58 meters ( p < .001). GAQ scale‐responses showed overall improvement in overall 75% population, with a significant improvement in QoL ( p < .01). These changes returned to baseline at 1‐month withdrawal follow‐up. No adverse events were reported. These supplemental facts improved sexual desire, satisfaction with sex life, physical performance, and LUTS in young–old men, suggesting that they may be effective in patients in whom standard treatments are not suitable.